INCYTE CORP (INCY)

↓ Download CSV

CIK 0000879169 · Nasdaq · Services-Commercial Physical & Biological Research

  • Sector Services
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, INCYTE CORP reported revenue of $5.14B, up 21.2% from the prior year. The company was profitable, with a net margin of 25.0%. It held $6.96B in total assets against $1.79B in total liabilities.

Key ratios (FY2025)

29.5%
Operating margin
25.0%
Net margin
24.9%
Return on equity
+21.2%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$5.14B$4.24B$3.70B$3.39B$2.99B$2.67B$2.16B$1.88B$1.54B
Cost of Revenue$372.13M$312.07M$254.99M$207.00M$150.99M$131.33M$114.25M$94.12M$79.48M$58.19M
Operating Income$1.51B$61.37M$620.52M$579.44M$585.78M-$263.68M$402.01M$129.22M-$243.39M$145.00M
Net Income$1.29B$32.62M$597.60M$340.66M$948.58M-$295.70M$446.91M$109.49M-$313.14M$104.22M
EPS (Diluted)$6.41$0.15$2.65$1.52$4.27$-1.36$2.05$0.51$-1.53$0.54
Total Assets$6.96B$5.44B$6.78B$5.84B$4.93B$3.56B$3.43B$2.65B$2.30B$1.64B
Total Liabilities$1.79B$2.00B$1.59B$1.47B$1.16B$949.65M$828.34M$719.79M$671.95M$1.22B
Shareholders' Equity$5.17B$3.45B$5.19B$4.37B$3.77B$2.61B$2.60B$1.93B$1.63B$419.47M
Cash & Equivalents$3.10B$1.69B$3.21B$2.95B$2.06B$1.51B$1.83B$1.16B$899.51M$652.34M
Operating Cash Flow$1.41B$335.34M$496.49M$969.94M$749.49M-$124.60M$710.66M$336.23M-$92.99M$304.76M
Capital Expenditures$77.83M$181.01M$187.38M$78.06M$73.48M$111.02M$120.28M
Shares Outstanding198.46M193.43M224.29M222.75M221.08M219.49M216.18M213.27M211.26M188.85M